Grufity logoGrufity logo

CMPS

10.05USD-0.43(-4.10%)Market Closed

COMPASS Pathways plc

Market Summary

USD10.05-0.43Market Closed
-4.10%

CMPS Stock Price

RSI Chart

Valuation

Market Cap

467.3M

Price/Earnings

-5.58

Price/Cashflow

-6.04

MarketCap/EBT

-5.61

Price/Earnings

Profitability

Return on Equity

-37.27%

Return on Assets

-35.07%

Fundamentals

Earnings

Earnings (TTM)

-83.7M

Earnings Y/Y

-20.02%

Earnings Q/Q

0.63%

Price Action

52 Week Range

8.8621.50
(Low)(High)

Last 7 days

0.9%

Last 30 days

-2.1%

Last 90 days

-42.6%

Financial Health

Current Ratio

17.53

Investor Care

Shares Dilution (1Y)

1.98%

Diluted EPS (TTM)

-2

Financials for COMPASS Pathways

Income Statement (Last 12 Months)
Description(%) Q/Q
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Assets-12.3%239272301315335
  Current Assets-13.0%232267295313334
    Cash Equivalents-15.0%207244273294316
  Net PPE64.1%10000
Liabilities12.2%14131698
  Current Liabilities13.3%13121598
Shareholder's Equity-13.5%225260284305327
  Retained Earnings-11.0%-211.85-190.81-169.64-144.00-128.10
  Additional Paid-In Capital0.7%451448445441439
Shares Outstanding1.0%42424242-
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Cashflow From Operations-0.4%-77,392.00-77,090.00-67,745.00-62,130.00-62,147.00
  Share Based Compensation12.6%11,37510,1018,6397,22310,151
Cashflow From Investing-94.5%-673.00-346.00-334.00-273.00-202.00
Cashflow From Financing-99.2%1,256155,877156,646155,857294,061

Risks

What is the probability of a big loss on CMPS?

88.5%


Probability that COMPASS Pathways stock will be more than 20% underwater in next one year

50%


Probability that COMPASS Pathways stock will be more than 30% underwater in next one year.

42.3%


Probability that COMPASS Pathways stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CMPS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if COMPASS Pathways was unfortunately bought at previous high price.

Returns

Cumulative Returns on CMPS

Which funds bought or sold CMPS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-16
Front Row Advisors LLC
NEW
-
2,000
2,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-28,000
-
-%
2022-11-15
STATE STREET CORP
REDUCED
-13.23
-40,000
248,000
-%
2022-11-15
HARBOUR INVESTMENTS, INC.
UNCHANGED
-
-
-
-%
2022-11-15
Balyasny Asset Management LLC
NEW
-
155,000
155,000
-%
2022-11-15
Almanack Investment Partners, LLC.
NEW
-
1,000
1,000
-%
2022-11-15
Anson Funds Management LP
SOLD OFF
-100
-325,000
-
-%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
JANE STREET GROUP, LLC
NEW
-
437,000
437,000
-%
2022-11-14
WELLS FARGO & COMPANY/MN
REDUCED
-0.15
-22,000
2,149,000
-%

1–10 of 40

Latest Funds Activity

Are funds buying CMPS calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own CMPS

COMPASS Pathways News

Marketscreener.com

Berenberg Resumes COMPASS Pathways at Buy With $33 Price Target.7 days ago

Value the Markets

CMPS Fair Value

Recent SEC filings of COMPASS Pathways

View All Filings
Date Filed Form Type Document
Nov 03, 2022
8-K
Current Report
Nov 03, 2022
10-Q
Quarterly Report

Latest Insider Trading transactions for CMPS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-08-01
Nath Kabir
ACQUIRED
-
-
50,000
Chief Executive Officer
2022-03-29
Malievskaia Ekaterina
SOLD
-79,522.6
12.48
-6,372
Chief Innovation Officer
2022-03-29
Goldsmith George Jay
SOLD
-79,522.6
12.48
-6,372
Chief Executive Officer
2022-03-29
Jenkins Annalisa
SOLD
-42,232.3
12.48
-3,384
-
2022-03-29
Norton David Y
SOLD
-42,232.3
12.48
-3,384
-
2022-02-01
Goldsmith George Jay
ACQUIRED
-
-
29,000
Chief Executive Officer
2022-02-01
Goldsmith George Jay
ACQUIRED
-
-
13,000
Chief Executive Officer
2022-02-01
Malievskaia Ekaterina
ACQUIRED
-
-
29,000
Chief Innovation Officer

1–10 of 13

George J. Goldsmith
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

CMPS Income Statement

2022-09-30
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
OPERATING EXPENSES:    
Research and development$ 13,977$ 12,197$ 45,259$ 30,434
General and administrative11,5599,57132,95324,464
Total operating expenses25,53621,76878,21254,898
LOSS FROM OPERATIONS:(25,536)(21,768)(78,212)(54,898)
OTHER INCOME, NET:    
Other income, net3,20603,5802
Foreign exchange gains1,0963,3644,3872,171
Benefit from R&D tax credit2,9832,6189,9826,733
Total other income, net7,2855,98217,9498,906
Loss before income taxes(18,251)(15,786)(60,263)(45,992)
Income tax expense(120)(63)(316)(100)
Net loss(18,371)(15,849)(60,579)(46,092)
Other comprehensive loss:    
Foreign exchange translation adjustment(15,156)(8,401)(39,483)(6,768)
Comprehensive loss$ (33,527)$ (24,250)$ (100,062)$ (52,860)
Net loss per share - basic (in dollars per share)$ (0.43)$ (0.38)$ (1.43)$ (1.17)
Net loss per share - diluted (in dollars per share)$ (0.43)$ (0.38)$ (1.43)$ (1.17)
Weighted average ordinary shares outstanding - basic (in shares)42,525,85541,708,22042,377,89539,378,824
Weighted average ordinary shares outstanding - diluted (in shares)42,525,85541,708,22042,377,89539,378,824

CMPS Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
CURRENT ASSETS:  
Cash and cash equivalents$ 173,076$ 273,243
Restricted cash155104
Prepaid income tax465332
Prepaid expenses and other current assets44,75521,621
Total current assets218,451295,300
NON-CURRENT ASSETS:  
Investment432525
Property and equipment, net555398
Operating lease right-of-use assets2,3383,696
Deferred tax assets2,445766
Other assets299213
Total assets224,520300,898
CURRENT LIABILITIES:  
Accounts payable19,8852,564
Accrued expenses and other liabilities7,81710,308
Operating lease liabilities - current1,8312,235
Total current liabilities29,53315,107
NON-CURRENT LIABILITIES  
Operating lease liabilities - non-current4251,379
Total liabilities29,95816,486
Commitments and contingencies (Note 12)
SHAREHOLDERS' EQUITY:  
Additional paid-in capital454,957444,750
Accumulated other comprehensive (loss)/income(30,643)8,840
Accumulated deficit(230,220)(169,641)
Total shareholders' equity194,562284,412
Total liabilities and shareholders' equity224,520300,898
Ordinary shares  
SHAREHOLDERS' EQUITY:  
Ordinary and deferred shares440435
DEFERRED SHARES  
SHAREHOLDERS' EQUITY:  
Ordinary and deferred shares$ 28$ 28